{
    "clinical_study": {
        "@rank": "9911", 
        "arm_group": [
            {
                "arm_group_label": "Aspirin", 
                "arm_group_type": "Experimental", 
                "description": "Low dose aspirin (100 mg) starting between 13 and 16 weeks of pregnancy until 36 weeks of pregnancy, taken at night."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo (identical to low dose aspirin (100 mg)) starting between 13 and 16 weeks of pregnancy until 36 weeks of pregnancy, taken at night."
            }
        ], 
        "brief_summary": {
            "textblock": "Preeclampsia is one of the three leading causes of maternal morbidity and mortality all over\n      the world.  The use of low dose aspirin has been mentioned in several studies  with\n      promising results.  The investigators decided to evaluate the use of low dose aspirin,\n      starting between 13 and 16 weeks of pregnancy, based on clinical characteristics only to\n      reduce the incidence of preeclampsia."
        }, 
        "brief_title": "Low Dose Aspirin for the Prevention of Preeclampsia", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Preeclampsia", 
        "condition_browse": {
            "mesh_term": "Pre-Eclampsia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Gestational age between 13 and 16 weeks of pregnancy\n\n          -  High risk of preeclampsia, based in clinical risk factors as:\n\n        Preeclampsia in a previous pregnancy Mother or sister that developed preeclampsia in a\n        previous pregnancy Diabetes Mellitus (insulin dependant) Chronic Hypertension\n        (with/without proteinuria) Body Mass Index > 32 Multiple pregnancy Lupus or other\n        autoimmune disorder Chronic Renal Disease.\n\n        Exclusion Criteria:\n\n          -  Blood coagulation disorders of any kind\n\n          -  Peptic ulcers\n\n          -  Allergy to aspirin\n\n          -  Chronic use of anti-inflammatory drugs\n\n          -  Fetus with mayor anomalies"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "476", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01890005", 
            "org_study_id": "MHST2013-05"
        }, 
        "intervention": [
            {
                "arm_group_label": "Aspirin", 
                "description": "Low dose aspirin (100 mg) starting between 13 and 16 weeks of pregnancy until 36 weeks of pregnancy, taken at night.", 
                "intervention_name": "Aspirin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo starting between 13 and 16 weeks of pregnancy until 36 weeks of pregnancy, taken at night.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Aspirin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Preeclampsia", 
            "Low dose aspirin", 
            "Fetal growth restriction", 
            "Neonatal death", 
            "Stillbirth", 
            "Abruptio placenta"
        ], 
        "lastchanged_date": "June 28, 2013", 
        "location": {
            "contact": {
                "email": "revelarde_14@yahoo.es", 
                "last_name": "Rodrigo Velarde, MD"
            }, 
            "contact_backup": {
                "email": "oreyespanama@yahoo.es", 
                "last_name": "Osvaldo Reyes, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Panama", 
                    "country": "Panama"
                }, 
                "name": "Saint Thomas Maternity Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Osvaldo Reyes, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Rodrigo Velarde, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Panama"
        }, 
        "number_of_arms": "2", 
        "official_title": "Low Dose Aspirin Between 13 and 16 Weeks of Pregnancy for the Prevention of Preeclampsia. Double Blind, Randomized, Controlled Trial.", 
        "overall_contact": {
            "email": "revelarde_14@yahoo.es", 
            "last_name": "Rodrigo Velarde, MD"
        }, 
        "overall_contact_backup": {
            "email": "oreyespanama@yahoo.es", 
            "last_name": "Osvaldo Reyes, MD"
        }, 
        "overall_official": [
            {
                "affiliation": "Saint Thomas Maternity Hospital", 
                "last_name": "Osvaldo Reyes, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Saint Thomas Maternity Hospital", 
                "last_name": "Rodrigo Velardee, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Saint Thomas Maternity Hospital", 
                "last_name": "Ameth Hawkins, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Saint Thomas Maternity Hospital", 
                "last_name": "Ana Moreno, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Ministry of Health: Panama", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The number of cases of preeclampsia that appear in both groups before 34 weeks of pregnancy", 
            "measure": "Prevention of preeclampsia", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01890005"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Saint Thomas Hospital, Panama", 
            "investigator_full_name": "Osvaldo A. Reyes T.", 
            "investigator_title": "Coordinator of Research", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The number of cases of preeclampsia that appear in both groups between 37 and 41 weeks of pregnancy.", 
                "measure": "Prevention of preeclampsia at term", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "The number of cases of stillbirths that appear in both groups at any given time during pregnancy.", 
                "measure": "Stillbirth", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "The number of cases of neonatal deaths that appear in both groups, regardless of the cause.", 
                "measure": "Neonatal deaths", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "The number of cases that require admittance to the Neonatal Intensive Care Unit in both groups in the first 28 days after birth.", 
                "measure": "Neonatal intensive care unit admissions.", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "description": "The number of cases of abruptio placenta that appear in both groups at any given time during pregnancy.", 
                "measure": "Abruptio placenta", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "description": "The number of cases of fetal growth restriction, defined as a fetal weight below the 10th percentile and an abnormal umbilical cord doppler that appear in both groups at any given time during pregnancy.", 
                "measure": "Fetal Growth Restriction", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "Saint Thomas Hospital, Panama", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Saint Thomas Hospital, Panama", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}